Canada’s review of Pfizer-BioNTech’s COVID-19 vaccine for children between the ages of five and 11 should be completed within the next “one to two weeks,” Health Canada’s chief medical adviser said Friday.
More...
From
http://start.westnet.ca News
News Provided By
WestNet Wireless Internet